Dimension Therapeutics Further Expands Leadership Team; Appoints Accomplished Industry Leader Jean M. Franchi As Chief Financial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dimension Therapeutics, Inc. ("Dimension" or the "Company"), a leading rare disease company advancing novel, liver-directed treatments for diverse genetic disorders, today announced that Jean M. Franchi has been appointed to the newly created position of Chief Financial Officer and Treasurer. Ms. Franchi brings more than 20 years of experience building and leading corporate and divisional financial teams from the R&D stage to commercial operations in the public and private pharmaceutical, biotech, and diagnostics sectors.

Suggested Articles

Last month, rumors out of Bloomberg whispered that Gilead, more known for its COVID-19 work these days, was gearing up for a major stake in Arcus.

The NGOs think Big Pharma controls the agenda of the IMI, leading it to prioritize areas that are profitable for drugmakers over public health needs.

Scientists at McMaster University and the University of Toronto have formed Empirica Therapeutics to bring a CAR-T for glioblastoma into the clinic.